|
(11) | EP 0 772 444 A1 |
(12) |
|
|
|
|
|||||||||||||||||||
(54) | USE OF THE ENANTIOMERS OF OXAZOPHOSPHORINES, E.G. IFOSFAMIDE, IN ANTI-TUMOUR THERAPY, FOR REDUCING SIDE-EFFECTS |